Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?

Company Overview - American Well Corporation (AMWL) is a member of the Medical sector, which includes 926 individual stocks and currently holds a Zacks Sector Rank of 9 [2] - AMWL is part of the Medical Info Systems industry, which consists of 42 individual stocks and is ranked 138 in the Zacks Industry Rank [6] Performance Analysis - AMWL has gained approximately 14.3% year-to-date, outperforming the average loss of about 1% in the Medical group [4] - Over the past three months, the Zacks Consensus Estimate for AMWL's full-year earnings has increased by 36.6%, indicating improved analyst sentiment and a stronger earnings outlook [4] - In comparison, Catalyst Pharmaceutical (CPRX) has returned 4.2% year-to-date and has a Zacks Rank of 1 (Strong Buy) with a 13% increase in the consensus EPS estimate over the past three months [5] Industry Comparison - The Medical Info Systems industry has experienced an average loss of 18% year-to-date, highlighting AMWL's superior performance within its industry [6] - The Medical - Drugs industry, to which Catalyst Pharmaceutical belongs, is ranked 93 and has moved -2.7% so far this year [6] Investment Outlook - Investors interested in Medical stocks should continue to monitor American Well Corporation and Catalyst Pharmaceutical for their solid performance [7]